BioMed Research International

BioMed Research International / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 757502 |

Aichurek Soultanova, Alexandra R. Panneck, Amir Rafiq, Wolfgang Kummer, "Terminally Differentiated Epithelial Cells of the Thymic Medulla and Skin Express Nicotinic Acetylcholine Receptor Subunit α3", BioMed Research International, vol. 2014, Article ID 757502, 9 pages, 2014.

Terminally Differentiated Epithelial Cells of the Thymic Medulla and Skin Express Nicotinic Acetylcholine Receptor Subunit α3

Academic Editor: Koichiro Kawashima
Received22 Apr 2014
Accepted13 Jun 2014
Published03 Jul 2014


In the thymus, T cell maturation is influenced by cholinergic signaling, and the predominantly expressed receptor is the α3-subunit of nicotinic acetylcholine receptors, encoded by the chrna3 gene. We here determined its cellular distribution utilizing an appropriate eGFP-expressing reporter mouse strain. Neither T cells (CD4, CD8) nor mesenchymal cells (desmin-positive) expressed eGFP. In the thymic medulla, eGFP-positive cells either were scattered or, more frequently, formed small clusters resembling Hassall’s corpuscles. Immunolabeling revealed that these cells were indeed terminally differentiated epithelial cells expressing keratin 10 (K10) but neither typical cortical (K8, K18) nor medullary keratins (K5, K14). These labeling patterns reflected those in the epidermis of the skin, where overlap of K10 and eGFP expression was seen in the stratum granulosum, whereas underlying basal cells displayed K5-immunoreactivity. A substantial portion of thymic eGFP-positive cells was also immunoreactive to chromogranin A, a peptide previously reported in epidermal keratinocytes in the stratum granulosum. Its fragment catestatin has multiple biological activities, including suppression of proinflammatory cytokine release from macrophages and inhibition of α3β4 nAChR. The present findings suggest that its thymic production and/or release are under cholinergic control involving nAChR containing the α3-subunit.

1. Introduction

The thymus is the site of step-wise maturation of naïve T cells from immature thymocytes which occurs along with positive and negative selection processes while thymocytes migrate from the cortex to the medulla. These processes are influenced by cholinergic signaling [14], and acetylcholine (ACh) is endogenously synthesized in the thymus [57].

Signaling via nicotinic ACh receptors (nAChR) has received particular attention. These receptors are pentamers composed of various subunit combinations. The “muscle type” nAChR originally identified at the motor endplate consists of two α1-, one β1-, one ε- (or γ- at fetal stage), and one δ-subunit, and these are also expressed by myoid [8, 9] and epithelial cells of the thymic medulla [1013]. Thymic expression and presentation of muscle-type nAChR subunits have been associated with a frequent (85%) variant of myasthenia gravis, a disease of the motor endplate, where autoantibodies against such subunits are formed, as the thymus frequently shows abnormal structure in this condition and thymectomy is beneficial for the patients [14].

“Neuronal” nAChR are homo- or heteromers of α-subunits 2–7 and 9-10 (α8 is expressed only in chicken) and β-subunits 2–4 [1517]. Despite their designation as “neuronal” they are widely expressed outside the nervous system including the thymus [18, 19]. Amongst them, subunits α3, α5, and β4 exhibit highest expression in early postnatal mouse thymus, reaching 7–15% of mRNA content found in brain as standard [19]. Their genes—chrna3, chrna5, and chrnb4—are clustered on chromosome 9 in mice, and, when coexpressed, the translated proteins assemble to functional α3(α5)β4 nAChR with either 2 α- and 3 β-subunit or 3 α- and 2 β-subunit chains [15, 20]. The α3-subunit is essential for receptor function and may occur with or without an additional α5-subunit in these receptors while the α5-subunit does not form functional receptors without additional α-subunits [15]. Messenger RNAs coding for these subunits have been detected in isolated thymocytes and cultured thymic epithelial cells (TEC) obtained from children undergoing corrective cardiac surgery [18], but it is still unclear which specific thymic cell types express these receptors in situ.

In view of the reported specificity problems associated with immunohistochemical detection of nAChR subunits [21], we utilized a reporter mouse strain expressing eGFP under the control of the chrna3 promoter coding for the essential α3-subunit [22]. To further characterize and identify eGFP-positive cells in the thymus, tissue sections were subjected to immunohistochemistry with marker antibodies for subsets of thymocytes (CD4, CD8), myoid and mesenchymal (desmin) and thymic epithelial cells. Thymic epithelial cells are heterogeneous and can be classified according to various criteria. A broad classification divides them into four general types (with further subpopulations [23, 24]): (a) subcapsular/paraseptal/perivascular, (b) cortical, (c) medullary (mTEC), and (d) terminally differentiated mTEC, usually arranged in Hassall’s corpuscles [2528]. These types differ in their intermediate filament content, with cortical and a small population of mTEC expressing keratins typical for simple epithelia (K8, K18) [23, 28, 29], the majority of mTEC keratins characteristic for immature basal cells of stratified epithelia, that is, K5 and K14 [24, 28, 30], and terminally differentiated cells of Hassall’s corpuscles (in human) and Hassall’s corpuscles-like structures (in mice) expressing K10 [31].

2. Materials and Methods

2.1. Animals and Tissue Collection

Transgenic mice expressing eGFP under chrna3 promoter [22] were killed with an overdose of isoflurane (Abbott, Wiesbaden, Germany). Animals of either gender () were transcardially perfused with heparin-containing rinsing solution [32] followed by either 4% paraformaldehyde in 0.1 M phosphate buffer () or Zamboni fixative (2% paraformaldehyde, 15% saturated picric acid in 0.1 M phosphate buffer, pH 7.4). Thymi and hairy skin of the head were dissected and fixed overnight by immersion in the same fixative used for perfusion. In 5 additional animals, tissues were immersion-fixed overnight in Zamboni fixative without prior perfusion. Specimens were washed in 0.1 M phosphate buffer, , for 30 h, incubated overnight in 18% sucrose in 0.1 M phosphate buffer, and frozen in OCT compound (Sakura Finetek, Staufen, Germany) using liquid nitrogen.

2.2. Immunohistochemistry

Thymi and hairy skin of the head were cut with a cryostat into 4–10 μm thick sections and air-dried for 1 h. Nonspecific protein binding sites were saturated with 10% horse serum, 0.5% Tween, and 0.1% BSA in PBS (0.005 M phosphate buffer, , with 0.45% NaCl). Sections were incubated for 16 h with primary antibodies diluted in PBS with doubled salt concentration and containing 0.01% NaN3. Each antibody was applied to thymi from at least 6 animals. Antibody dilutions and sources are specified in Table 1. After washing in PBS, sections were covered with Cy3-conjugated donkey anti-rabbit IgG (1 : 2000; Chemicon, Darmstadt, Germany) or donkey anti-rat IgG (1 : 1000; Dianova, Hamburg, Germany) for 1 h, washed, postfixed in 4% paraformaldehyde in 0.1 M phosphate buffer, washed again, and mounted in carbonate-buffered glycerol (1 : 1, ). Controls were run by replacing primary antibodies with unrelated isotypes from the same species and by omission of first antibodies. Sections were evaluated with an Axioplan 2 epifluorescence microscope equipped with an AxioCam MRm camera system (Zeiss, Jena, Germany). Except overall adjustment of brightness, no further manipulations of digital images were performed.

TargetImmunogenHostCloneDilutionCatalog numberCompany

CD4Not specifiedRatMonoclonal,
clone RM4-5
1 : 400IH93-0042-91eBioscience, Frankfurt am Main, Germany

CD8Not specifiedRatMonoclonal,
clone 53-6.7
1 : 400IH93-0081-91eBioscience, Frankfurt am Main, Germany

Chromogranin ASynthetic peptide corresponding to residues near the C-terminus of human chromogranin ARabbitPolyclonal1 : 251782-1Epitomics, Cambridge, UK

DesminSynthetic peptide corresponding to C-terminus of human desminRabbitMonoclonal,
clone Y66
1 : 200–1 : 80004-585Merck Millipore, Darmstadt, Germany

Keratin 5Synthetic peptide corresponding to C-terminus of human keratin 5RabbitMonoclonal,
clone SP27
1 : 50–1 : 200SPB-M3270Spring, Pleasanton, CA, USA

Keratin 8Synthetic peptide corresponding to C-terminus of human keratin 8RabbitMonoclonal,
clone SP102
1 : 50SPB-M4020Spring, Pleasanton, CA, USA

Keratin 10 C-terminus of the mouse keratin 10 Rabbit Polyclonal1 : 400 PRB-159PCovance, Münster, Germany

Keratin 14Synthetic peptide corresponding to C-terminus of human keratin 14RabbitMonoclonal,
clone SP53
1 : 400SPB-M3534Spring, Pleasanton, CA, USA

Keratin 18Synthetic peptide corresponding to C-terminus of human keratin 18RabbitMonoclonal,
clone SP69
1 : 200SPB-M3694Spring, Pleasanton, CA, USA

3. Results

The major nicotinic receptor mediating synaptic transmission in autonomic ganglia is a heteropentamer of α3(α5)β4 subunits [15, 33]. Accordingly, autonomic nerve fibers surrounding thymic arteries exhibited intense eGFP fluorescence (Figure 1(a)). Besides these nerve fibers, positive cells were observed in the thymic medulla with some preference to the corticomedullary junction, but practically sparing the external cortex (Figures 1(b) and 1(c)). Such cells typically formed clusters. The larger clusters showed characteristic morphology of murine Hassall’s corpuscle-like structures. Infrequently observed singular eGFP-positive cells and those forming groups of two or three, displayed variable shape, ranging from round to oval to elongated with processes emerging from the cell body (Figures 1(d)1(i)). According to this complex shape, these eGFP-positive cells were not thymocytes and did not express CD4 or CD8 (Figure 2).

Desmin is a marker for thymic myoid cells and mesenchymal cells [9]. Accordingly, immunolabeling revealed a network of fine processes in the thymic medulla and a few positive cells bodies. Colocalization with eGFP fluorescence was not observed (Figure 3).

K8- and K18-immunoreactive epithelial cell processes formed a dense network in the cortex, and a small population of less branched mTEC was also K8- and K18-immunoreactive, as previously described [34]. Neither of these antibodies, however, labeled eGFP-positive cells (Figures 4(a) and 4(b)). In the medulla, a dense mesh of K5- and K14-immunoreactive cell processes was noted. Such processes surrounded eGFP-positive cells which were larger than keratin-immunoreactive cell bodies and were K5/K14-negative (Figures 4(c) and 4(d)). This spatial arrangement resembled that of the epidermis where K5 is expressed by the basal cells and its expression ceases when keratinocytes terminally differentiate in the stratum granulosum [35, 36]. Accordingly, we observed eGFP fluorescence in the K5-negative stratum granulosum of hairy skin and K5-positive cells in the underlying stratum basale and the lowermost stratum spinosum (Figure 5(a)). In the epidermis, keratinocytes switch to K10 expression in the stratum spinosum which is kept in the stratum granulosum. This partly overlaps with eGFP fluorescence which is first seen in the stratum granulosum and extends into the stratum corneum (Figure 5(b)). The same pattern of extensive but not complete overlap of eGFP- and K10-immunoreactivity was found in the thymus (Figure 5(c)).

In addition, there was partial colocalization of eGFP with chromogranin A (CGA) in the thymus. CGA-immunoreactive cells were found mainly in the medulla, often attached to Hassall’s corpuscle-like structures, as previously reported [37, 38] (Figure 6). CGA-immunoreactive granules were observed in a population of eGFP-positive cells, although CGA+/eGFP and CGA/eGFP+ cells were also present in about equal proportions (Figure 6).

4. Discussion

The present study demonstrates that the most abundantly expressed nAChR subunit in the murine thymus, the α3-subunit, is localized to a distinct mTEC type, that is, terminally differentiated mTEC expressing K10. In the skin, eGFP expression driven by the chrna3 promoter was more restricted than expected from previous immunohistochemical studies utilizing α3-subunit antibodies [39, 40], which possibly originates from the noted specificity problems of nAChR subunit antibodies documented by the use of respective gene-deficient mice [21]. In the epidermis, where keratinocytes undergo stepwise differentiation while migrating through the different layers towards the surface, we saw K10 prior to eGFP expression and eGFP shortly after keratinization when K10 was no longer detectable. This sequence of expression (K10 before nAChRα3) suggests that the known promoting effect of nicotine on K10 expression by keratinocytes [41] is not driven by α3-subunit containing nAChR but likely by another nAChR subtype, for example, α7 or α9α10 nAChR, also known to be expressed in keratinocytes [39, 4143].

Assuming the same sequence of differentiation in Hassall’s corpuscle-like structures, the few K10+/eGFP and K10/eGFP+ cells in the thymic medulla would not represent an entirely distinct cell population but mTEC at corresponding intermediate stages of differentiation. When K10 is ectopically expressed in K5-positive mTEC, the thymus presents premature involution with increased apoptosis and reduced proliferation of thymocytes [44] but this does not necessarily allow conclusions about physiologically K10-expressing terminal mTEC.

Terminally differentiated mTEC, also characterized by expression of involucrin, no longer express the autoimmune regulator (Aire) which plays a pivotal role in establishing self-tolerance by negative selection and FoxP3+ regulatory T cell (Treg) production [31]. Human Hassall’s corpuscles express thymic stromal lymphopoietin which activates medullary dendritic cells to express high levels of CD28 ligands (CD80 and CD86) [45]. Such activated dendritic cells induce the generation of CD4+CD8CD25+ T cells, leading to the suggestion that Hassall’s corpuscles, via dendritic cells, trigger secondary positive selection of medium-to-high affinity self-reactive T cells resulting in Treg generation in the thymic medulla [45]. In mice, however, Treg develop normally in lymphotoxin β-receptor-deficient mice which lack terminally differentiated mTEC as judged from the absence of involucrin+ cells in the medulla [31, 46]. Thus, the function of terminally differentiated mTEC clusters is still unclear.

CGA, originally isolated from chromaffin cells of the adrenal medulla and later found to be produced by other endocrine cell types, is also expressed in epidermal keratinocytes in the stratum granulosum [47] which is again in parallel to CGA-immunoreactivity in Hassall’s corpuscles [37, 38]. Its peptide fragment catestatin has multiple biological activities, including suppression of proinflammatory cytokine release by and increasing p-STAT3 levels in peritoneal and bone marrow-derived macrophages [48]. The present findings suggest that its thymic production and/or release are under cholinergic control involving nAChR containing the α3-subunit. On the other hand, catestatin is an inhibitor of α3β4 nAChR [49], so that it might act in an autoinhibitory feedback in α3-subunit-expressing terminally differentiated mTEC.

Except terminally differentiated mTEC and autonomic nerve endings, no further cellular elements of the thymus expressed chrna3-driven eGFP in the present study. In contrast, RT-PCR revealed mRNA coding for α3- and β4-subunits in isolated human CD4+CD8+ thymocytes [18]. This discrepancy might be due to species differences or incomplete expression of the transgene in the mouse strain used in this study.

In conclusion, the present study identifies nAChR α3-subunit expression by terminally differentiated mTEC. Their function is still unclear, which has been ascribed at least partly to the lack of adequate models allowing for isolating these cells [31], a problem that might be overcome utilizing the nAChRα-eGFP mouse strain analyzed in this study.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The authors thank Dr. Ines Ibanez-Tallon, MDC Berlin, Germany, for providing the Chrna-eGFP mouse strain, and M. Bodenbenner, A. Goldenberg, T. Papadakis, and L. Renno for skillful technical assistance. This study was supported by HMWK, LOEWE Research Focus Non-neuronal cholinergic systems.


  1. A. J. Middlebrook, C. Martina, Y. Chang, R. J. Lukas, and D. DeLuca, “Effects of nicotine exposure on T cell development in fetal thymus organ culture: arrest of T cell maturation,” The Journal of Immunology, vol. 169, no. 6, pp. 2915–2924, 2002. View at: Publisher Site | Google Scholar
  2. A. Antonica, F. Magni, L. Mearini, and N. Paolocci, “Vagal control of lymphocyte release from rat thymus,” Journal of the Autonomic Nervous System, vol. 48, no. 3, pp. 187–197, 1994. View at: Publisher Site | Google Scholar
  3. W. Maslinski, E. Grabczewska, H. Laskowska-Bozek, and J. Ryzewski, “Expression of muscarinic cholinergic receptors during T cell maturation in the thymus,” European Journal of Immunology, vol. 17, no. 7, pp. 1059–1063, 1987. View at: Publisher Site | Google Scholar
  4. J. C. Nordman, P. Muldoon, S. Clark, M. I. Damaj, and N. Kabbani, “The alpha-4 nicotinic receptor promotes CD4+ T-cell proliferation and a helper T-cell immune response,” Molecular Pharmacology, vol. 85, no. 1, pp. 50–61, 2014. View at: Google Scholar
  5. I. Rinner, A. Globerson, K. Kawashima, W. Korsatko, and K. Schauenstein, “A possible role for acetylcholine in the dialogue between thymocytes and thymic stroma,” NeuroImmunoModulation, vol. 6, no. 1-2, pp. 51–55, 1999. View at: Publisher Site | Google Scholar
  6. M. A. Tria, G. Vantini, M. G. Fiori, and A. Rossi, “Choline acetyltransferase activity in murine thymus,” Journal of Neuroscience Research, vol. 31, no. 2, pp. 380–386, 1992. View at: Publisher Site | Google Scholar
  7. K. Kawashima and T. Fujii, “Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function,” Frontiers in Bioscience, vol. 9, pp. 2063–2085, 2004. View at: Publisher Site | Google Scholar
  8. M. Schluep, N. Willcox, A. Vincent, G. K. Dhoot, and J. Newsom-Davis, “Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study,” Annals of Neurology, vol. 22, no. 2, pp. 212–222, 1987. View at: Publisher Site | Google Scholar
  9. A. Wakkach, S. Poea, E. Chastre et al., “Establishment of a human thymic myoid cell line: phenotypic and functional characteristics,” The American Journal of Pathology, vol. 155, no. 4, pp. 1229–1240, 1999. View at: Publisher Site | Google Scholar
  10. E. K. Engel, J. L. Trotter, D. E. McFarlin, and C. L. McIntosh, “Thymic epithelial cell contains acetylcholine receptor,” The Lancet, vol. 1, no. 8025, pp. 1310–1311, 1977. View at: Google Scholar
  11. L. M. Wheatley, D. Urso, K. Tumas, J. Maltzman, E. Loh, and A. I. Levinson, “Molecular evidence for the expression of nicotinic acetylcholine receptor α-chain in mouse thymus,” The Journal of Immunology, vol. 148, no. 10, pp. 3105–3109, 1992. View at: Google Scholar
  12. A. Wakkach, T. Guyon, C. Bruand, S. Tzartos, S. Cohen-Kaminsky, and S. Berrih-Aknin, “Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis,” The Journal of Immunology, vol. 157, no. 8, pp. 3752–3760, 1996. View at: Google Scholar
  13. R. Bruno, L. Sabater, E. Tolosa et al., “Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus,” Journal of Neuroimmunology, vol. 149, no. 1-2, pp. 147–159, 2004. View at: Publisher Site | Google Scholar
  14. S. Poëa-Guyon, P. Christadoss, R. le Panse et al., “Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis,” The Journal of Immunology, vol. 174, no. 10, pp. 5941–5949, 2005. View at: Google Scholar
  15. R. J. Lukas, J. P. Changeux, N. Le Novère et al., “International union of pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits,” Pharmacological Reviews, vol. 51, no. 2, pp. 397–401, 1999. View at: Google Scholar
  16. A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, and J. Boulter, “Alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3501–3506, 2001. View at: Publisher Site | Google Scholar
  17. L. R. Lustig, H. Peng, H. Hiel, T. Yamamoto, and P. A. Fuchs, “Molecular cloning and mapping of the human nicotinic acetylcholine receptor α10 (CHRNA10),” Genomics, vol. 73, no. 3, pp. 272–283, 2001. View at: Publisher Site | Google Scholar
  18. M. Mihovilovic, S. Denning, Y. Mai, L. P. Whichard, D. D. Patel, and A. D. Roses, “Thymocytes and cultured thymic epithelial cells express transcripts encoding α-3, α-5 and β-4 subunits of neuronal nicotinic acetylcholine receptors: preferential transcription of the α-3 and β-4 genes by immature CD4+8+ thymocytes,” Journal of Neuroimmunology, vol. 79, no. 2, pp. 176–184, 1997. View at: Publisher Site | Google Scholar
  19. Y. Kuo, L. Lucero, J. Michaels, D. DeLuca, and R. J. Lukas, “Differential expression of nicotinic acetylcholine receptor subunits in fetal and neonatal mouse thymus,” Journal of Neuroimmunology, vol. 130, no. 1-2, pp. 140–154, 2002. View at: Publisher Site | Google Scholar
  20. F. Mazzo, F. Pistillo, G. Grazioso et al., “Nicotine-modulated subunit stoichiometry affects stability and trafficking of α3/β4 nicotinic receptor,” The Journal of Neuroscience, vol. 33, no. 30, pp. 12316–12328, 2013. View at: Publisher Site | Google Scholar
  21. N. Moser, N. Mechawar, I. Jones et al., “Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures,” Journal of Neurochemistry, vol. 102, no. 2, pp. 479–492, 2007. View at: Publisher Site | Google Scholar
  22. S. Frahm, M. A. Ślimak, L. Ferrarese et al., “Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula,” Neuron, vol. 70, no. 3, pp. 522–535, 2011. View at: Publisher Site | Google Scholar
  23. D. B. Klug, C. Carter, E. Crouch, D. Roop, C. J. Conti, and E. R. Richie, “Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 20, pp. 11822–11827, 1998. View at: Publisher Site | Google Scholar
  24. N. M. Danzl, S. Jeong, Y. Choi, and K. Alexandropoulos, “Identification of novel thymic epithelial cell subsets whose differentiation is regulated by RANKL and Traf6,” PLoS ONE, vol. 9, no. 1, Article ID e86129, 2014. View at: Publisher Site | Google Scholar
  25. E. J. de Waal and L. H. Rademakers, “Heterogeneity of epithelial cells in the rat thymus,” Microscopy Research and Technique, vol. 38, no. 3, pp. 227–236, 1997. View at: Google Scholar
  26. H. J. Schuurman, C. F. Kuper, and M. D. Kendall, “Thymic microenvironment at the light microscopic level,” Microscopy Research and Technique, vol. 38, no. 3, pp. 216–226, 1997. View at: Google Scholar
  27. B. von Gaudecker, M. D. Kendall, and M. A. Ritter, “Immuno-electron microscopy of the thymic epithelial microenvironment,” Microscopy Research and Technique, vol. 38, no. 3, pp. 237–249, 1997. View at: Google Scholar
  28. E. N. Lee, J. K. Park, J. R. Lee et al., “Characterization of the expression of cytokeratins 5, 8, and 14 in mouse thymic epithelial cells during thymus regeneration following acute thymic involution,” Anatomy & Cell Biology, vol. 44, no. 1, pp. 14–24, 2011. View at: Google Scholar
  29. W. Savino and M. Dardenne, “Immunohistochemical studies on a human thymic epithelial cell subset defined by the anti-cytokeratin 18 monoclonal antibody,” Cell and Tissue Research, vol. 254, no. 1, pp. 225–231, 1988. View at: Google Scholar
  30. D. B. Klug, C. Carter, I. B. Gimenez-Conti, and E. R. Richie, “Cutting edge: thymocyte-independent and thymocyte-dependent phases of epithelial patterning in the fetal thymus,” The Journal of Immunology, vol. 169, no. 6, pp. 2842–2845, 2002. View at: Publisher Site | Google Scholar
  31. A. J. White, K. Nakamura, W. E. Jenkinson et al., “Lymphotoxin signals from positively selected thymocytes regulate the terminal differentiation of medullary thymic epithelial cells,” The Journal of Immunology, vol. 185, no. 8, pp. 4769–4776, 2010. View at: Publisher Site | Google Scholar
  32. W. G. Forssmann, S. Ito, E. Weihe, A. Aoki, M. Dym, and D. W. Fawcett, “An improved perfusion fixation method for the testis,” Anatomical Record, vol. 188, no. 3, pp. 307–314, 1977. View at: Publisher Site | Google Scholar
  33. S. Rassadi, A. Krishnaswamy, B. Pié, R. McConnell, M. H. Jacob, and E. Cooper, “A null mutation for the α3 nicotinic acetylcholine (ACh) receptor gene abolishes fast synaptic activity in sympathetic ganglia and reveals that ACh output from developing preeanglionic terminals is regulated in an activity-dependent retrograde manner,” Journal of Neuroscience, vol. 25, no. 37, pp. 8555–8566, 2005. View at: Publisher Site | Google Scholar
  34. E. Shezen, E. Okon, H. Ben-Hur, and O. Abramsky, “Cytokeratin expression in human thymus: immunohistochemical mapping,” Cell and Tissue Research, vol. 279, no. 1, pp. 221–231, 1995. View at: Publisher Site | Google Scholar
  35. R. Moll, W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler, “The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells,” Cell, vol. 31, no. 1, pp. 11–24, 1982. View at: Publisher Site | Google Scholar
  36. E. Fuchs and H. Green, “Changes in keratin gene expression during terminal differentiation of the keratinocyte,” Cell, vol. 19, no. 4, pp. 1033–1042, 1980. View at: Publisher Site | Google Scholar
  37. W. J. Ginda, M. Gratzl, A. Mayerhofer, and J. B. Warchol, “Chromogranin A immunoreactivity in epithelial cells of the thymus,” Folia Histochemica et Cytobiologica, vol. 34, no. 2, pp. 91–93, 1996. View at: Google Scholar
  38. M. Raica, S. Encicǎ, A. Motoc, A. M. Cîmpean, T. Scridon, and M. Bârsan, “Structural heterogeneity and immunohistochemical profile of Hassall corpuscles in normal human thymus,” Annals of Anatomy, vol. 188, no. 4, pp. 345–352, 2006. View at: Publisher Site | Google Scholar
  39. H. Kurzen, H. Berger, C. Jäger et al., “Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin,” Journal of Investigative Dermatology, vol. 123, no. 5, pp. 937–949, 2004. View at: Publisher Site | Google Scholar
  40. F. Kindt, S. Wiegand, V. Niemeier et al., “Reduced expression of nicotinic α subunits 3, 7, 9 and 10 in lesional and nonlesional atopic dermatitis skin but enhanced expression of α subunits 3 and 5 in mast cells,” British Journal of Dermatology, vol. 159, no. 4, pp. 847–857, 2008. View at: Publisher Site | Google Scholar
  41. S. A. Grando, R. M. Horton, T. M. Mauro, D. A. Kist, T. X. Lee, and M. V. Dahl, “Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation,” Journal of Investigative Dermatology, vol. 107, no. 3, pp. 412–418, 1996. View at: Publisher Site | Google Scholar
  42. J. Arredondo, V. T. Nguyen, A. I. Chernyavsky et al., “Central role of α7 nicotinic receptor in differentiation of the stratified squamous epithelium,” Journal of Cell Biology, vol. 159, no. 2, pp. 325–336, 2002. View at: Publisher Site | Google Scholar
  43. A. I. Chernyavsky, J. Arredondo, D. E. Vetter, and S. A. Grando, “Central role of α9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization,” Experimental Cell Research, vol. 313, no. 16, pp. 3542–3555, 2007. View at: Publisher Site | Google Scholar
  44. M. Santos, P. Río, S. Ruiz et al., “Altered T cell differentiation and notch signaling induced by the ectopic expression of keratin K10 in the epithelial cells of the thymus,” Journal of Cellular Biochemistry, vol. 95, no. 3, pp. 543–558, 2005. View at: Publisher Site | Google Scholar
  45. N. Watanabe, Y. H. Wang, H. K. Lee, T. Ito, W. Cao, and Y. Liu, “Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus,” Nature, vol. 436, no. 7054, pp. 1181–1185, 2005. View at: Publisher Site | Google Scholar
  46. V. C. Martins, T. Boehm, and C. C. Bleul, “Ltβr signaling does not regulate aire-dependent transcripts in medullary thymic epithelial cells,” The Journal of Immunology, vol. 181, no. 1, pp. 400–407, 2008. View at: Publisher Site | Google Scholar
  47. K. A. Radek, B. Lopez-Garcia, M. Hupe et al., “The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury,” Journal of Investigative Dermatology, vol. 128, no. 6, pp. 1525–1534, 2008. View at: Publisher Site | Google Scholar
  48. M. F. Rabbi, B. Labis, M. H. Metz-Boutigue, C. N. Bernstein, and J. E. Ghia, “Catestatin decreases macrophage function in two mouse models of experimental colitis,” Biochemical Pharmacology, vol. 89, no. 3, pp. 386–398, 2014. View at: Publisher Site | Google Scholar
  49. B. S. Sahu, J. Mohan, G. Sahu et al., “Molecular interactions of the physiological anti-hypertensive peptide catestatin with the neuronal nicotinic acetylcholine receptor,” Journal of Cell Science, vol. 125, no. 9, pp. 2323–2337, 2012. View at: Publisher Site | Google Scholar

Copyright © 2014 Aichurek Soultanova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

1224 Views | 634 Downloads | 3 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.